OraSure Technologies, Inc. provides point-of-care and home diagnostic tests, sample management solutions, and microbiome laboratory and analytical services. The Company's product portfolio is divided into diagnostics products and sample management solutions. Its business consists of the development, manufacture, marketing and sale of diagnostic products and specimen collection devices using its technologies, as well as other diagnostic products including immunoassays and other in vitro diagnostic tests that are used on other specimen types. Its diagnostic products include tests for diseases including COVID-19, HIV and Hepatitis C that are performed on a rapid basis at the point of care, and tests for drugs of abuse that are processed in a laboratory. Its business also includes molecular sample management solutions and services that are used by clinical laboratories, direct-to-consumer laboratories, researchers, pharmaceutical companies, and animal health service and product providers.
企業コードOSUR
会社名OraSure Technologies Inc
上場日Nov 17, 1986
最高経営責任者「CEO」Ms. Carrie Eglinton Manner
従業員数501
証券種類Ordinary Share
決算期末Nov 17
本社所在地220 E First St
都市BETHLEHEM
証券取引所NASDAQ Global Select Consolidated
国United States of America
郵便番号18015
電話番号15036416115
ウェブサイトhttps://www.orasure.com/
企業コードOSUR
上場日Nov 17, 1986
最高経営責任者「CEO」Ms. Carrie Eglinton Manner
過去5年間の配当金総支払額は
0.00
米ドルである。

データなし